138 related articles for article (PubMed ID: 17605116)
1. [Focus on tumor immunology of transitional cell carcinoma].
Olbert PJ; Schrader AJ; Hegele A; Hofmann R
Urologe A; 2007 Sep; 46(9):1135-7. PubMed ID: 17605116
[No Abstract] [Full Text] [Related]
2. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D
Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445
[TBL] [Abstract][Full Text] [Related]
3. [Studies on stimulation of immunological responses resulting from intravesical BCG instillation in patients with bladder carcinomas].
Tachibana M; Jitsukawa S; Deguchi N; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1680-5. PubMed ID: 3251104
[No Abstract] [Full Text] [Related]
4. [Urinary bladder carcinoma - research subject recruitment!].
Aktuelle Urol; 2014 May; 45(3):170-2. PubMed ID: 24932550
[No Abstract] [Full Text] [Related]
5. [The use of BCG vaccine for preventing recurrences of superficial bladder cancer].
Tkachuk VN; al-Shukri AKh; al-Khani F
Urol Nefrol (Mosk); 1996; (2):23-5. PubMed ID: 8677547
[TBL] [Abstract][Full Text] [Related]
6. Management of High-grade, Nonmuscle Invasive Urothelial Carcinoma in a Prepubertal Patient With TURBT and Intravesical BCG.
Rague JT; Lee RS
Urology; 2019 Feb; 124():257-259. PubMed ID: 30366046
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy of superficial bladder cancer].
Schmitz-Dräger BJ; Schattka SO; Ebert T
Urologe A; 1993 Sep; 32(5):374-81. PubMed ID: 8212422
[TBL] [Abstract][Full Text] [Related]
8. [Bladder carcinoma].
Lycklama à Nijeholt AA
Ned Tijdschr Geneeskd; 1992 Jun; 136(23):1097-102. PubMed ID: 1603169
[No Abstract] [Full Text] [Related]
9. Treatment of high-risk, non-muscle-invasive bladder cancer.
Lerner SP
Nat Clin Pract Urol; 2006 Aug; 3(8):398-9. PubMed ID: 16902498
[No Abstract] [Full Text] [Related]
10. [BCG-instillation therapy in superficial bladder tumor--host immune response elicited by local application of BCG].
Hayakawa M; Hatano T; Saito S; Miyazato T; Nakayama M; Igarashi M; Saita H
Nihon Hinyokika Gakkai Zasshi; 1987 Nov; 78(11):1972-81. PubMed ID: 3502480
[No Abstract] [Full Text] [Related]
11. Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder.
Zhang GK; Uke ET; Sharer WC; Borkon WD; Bernstein SM
J Urol; 1996 Jun; 155(6):1907-9. PubMed ID: 8618284
[TBL] [Abstract][Full Text] [Related]
12. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
Aust TR; Massey JA
Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
[TBL] [Abstract][Full Text] [Related]
13. [Our experience in treating patients with surface cancer of the bladder].
Matveev BP; Figurin KM; Romanov VA; Cheban NL
Urol Nefrol (Mosk); 1995; (5):35-8. PubMed ID: 8571484
[TBL] [Abstract][Full Text] [Related]
14. A new staging system for transitional cell carcinoma involvement of the prostate and reconfirmation studies of intravesical therapy for superficial bladder cancer.
Hudson MR
J Urol; 1996 Sep; 156(3):972-4. PubMed ID: 8709376
[No Abstract] [Full Text] [Related]
15. [Optimizing intravesical B.C.G].
Carballido Rodríguez JA
Actas Urol Esp; 1998; 22(10):805-10. PubMed ID: 9949568
[No Abstract] [Full Text] [Related]
16. Current problems and needs in the treatment of pT1 G3 bladder carcinoma.
Martínez Portillo FJ; Alken P
Int Urol Nephrol; 2002; 33(1):29-40. PubMed ID: 12090335
[No Abstract] [Full Text] [Related]
17. Pure squamous cell carcinoma after intravesical BCG treatment. A case report.
Yurdakul T; Avunduk MC; Piskin MM
Urol Int; 2005; 74(3):283-5. PubMed ID: 15812221
[TBL] [Abstract][Full Text] [Related]
18. Intravesical Bacillus Calmette-Guerin for treating bladder cancer.
Boyd LA
Urol Nurs; 2003 Jun; 23(3):189-91, 199; quiz 192. PubMed ID: 12861735
[TBL] [Abstract][Full Text] [Related]
19. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
Yates J; Stein B
Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant local BCG-immunotherapy in patients with urothel cancer of the bladder (author's transl)].
Flamm J; Grof F
Wien Med Wochenschr; 1981 Oct; 131(20):501-6. PubMed ID: 7314632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
